Literature DB >> 14622290

Identification and characterization of eukaryotic initiation factor 5A-2.

Paul M J Clement1, C Allen Henderson, Zandra A Jenkins, Zeljka Smit-McBride, Edith C Wolff, John W B Hershey, Myung Hee Park, Hans E Johansson.   

Abstract

The phylogenetically conserved eukaryotic translation initiation factor 5A (eIF5A) is the only known cellular protein to contain the post-translationally derived amino acid hypusine [Nepsilon-(4-amino-2-hydroxybutyl)lysine]. Both eIF5A and its hypusine modification are essential for sustained cell proliferation. Normally only one eIF5A protein is expressed in human cells. Recently, we identified a second human EIF5A gene that would encode an isoform (eIF5A-2) of 84% sequence identity. Overexpression of eIF5A-2 mRNA in certain human cancer cells, in contrast to weak normal expression limited to human testis and brain, suggests EIF5A2 as a potential oncogene. However, eIF5A-2 protein has not been described in human or mammalian cells heretofore. Here, we describe the identification of eIF5A-2 protein in human colorectal and ovarian cancer lines, SW-480 and UACC-1598, that overexpress eIF5A-2 mRNAs. Functional characterization of the human isoforms revealed that either human EIF5A gene can complement growth of a yeast strain in which the yeast EIF5A genes were disrupted. This indicates functional similarity of the human isoforms in yeast and suggests that eIF5A-2 has an important role in eukaryotic cell survival similar to that of the ubiquitous eIF5A-1. Detectable structural differences were also noted, including lack of immunological cross-reactivity, formation of different complexes with deoxyhypusine synthase, and Km values (1.5 +/- 0.2 vs. 8.3 +/- 1.4 microm for eIF5A-1 and -2, respectively) as substrates for deoxyhypusine synthase in vitro. These physical characteristics and distinct amino acid sequences in the C-terminal domain together with differences in gene expression patterns imply differentiated, tissue-specific functions of the eIF5A-2 isoform in the mammalian organism and in cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622290     DOI: 10.1046/j.1432-1033.2003.03806.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  50 in total

1.  Identification of endothelial proteins by MALDI-MS using a compact disc microfluidic system.

Authors:  Daniel Hirschberg; Sam Tryggvason; Magnus Gustafsson; Tomas Bergman; Jesper Swedenborg; Ulf Hedin; Hans Jörnvall
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  The effect of selenium enrichment on baker's yeast proteome.

Authors:  Karam El-Bayoumy; Arunangshu Das; Stephen Russell; Steven Wolfe; Rick Jordan; Kutralanathan Renganathan; Thomas P Loughran; Richard Somiari
Journal:  J Proteomics       Date:  2011-10-29       Impact factor: 4.044

3.  Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells.

Authors:  André K Langer; H Fai Poon; Gerald Münch; Bert C Lynn; Thomas Arendt; D Allan Butterfield
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

Review 4.  Elongation factor P mediates a novel post-transcriptional regulatory pathway critical for bacterial virulence.

Authors:  S Betty Zou; Hervé Roy; Michael Ibba; William Wiley Navarre
Journal:  Virulence       Date:  2011-03-01       Impact factor: 5.882

5.  GC7 blocks epithelial-mesenchymal transition and reverses hypoxia-induced chemotherapy resistance in hepatocellular carcinoma cells.

Authors:  Qing-Yun Zhou; Chao-Yong Tu; Chu-Xiao Shao; Wu-Ke Wang; Jing-De Zhu; Ying Cai; Jia-Yan Mao; Wei Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

6.  Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy.

Authors:  Eiki Ojima; Yasuhiro Inoue; Chikao Miki; Masaki Mori; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

7.  Knockdown of EIF5A2 inhibits the malignant potential of non-small cell lung cancer cells.

Authors:  Cheng Chen; Bojia Zhang; Shanshan Wu; Yongxiang Song; Jian Li
Journal:  Oncol Lett       Date:  2018-01-22       Impact factor: 2.967

Review 8.  Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.

Authors:  E C Wolff; K R Kang; Y S Kim; M H Park
Journal:  Amino Acids       Date:  2007-05-04       Impact factor: 3.520

9.  Expression of eukaryotic translation initiation factor 5A-2 (eIF5A-2) associated with poor survival in gastric cancer.

Authors:  Qiong Yang; Zaiyuan Ye; Qi Zhang; Zhongsheng Zhao; Hongjun Yuan
Journal:  Tumour Biol       Date:  2015-08-18

10.  Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A.

Authors:  Mainul Hoque; Hartmut M Hanauske-Abel; Paul Palumbo; Deepti Saxena; Darlene D'Alliessi Gandolfi; Myung Hee Park; Tsafi Pe'ery; Michael B Mathews
Journal:  Retrovirology       Date:  2009-10-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.